Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
Completed · Phase 3 · Has a placebo group
Conditions studied: Lymphoma, Non-Hodgkin
In brief
The purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF or generic name filgrastim) is better than G-CSF alone to mobilize and collect the optimal number of stem cells in non-Hodgkin's lymphoma patients for autologous transplantation.
Key facts
- Study ID
- NCT00103610
- Run by
- Genzyme, a Sanofi Company
- People needed
- 298
- Starts
- 2005-01-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2014-03-13
Who can join
Age: 18 and older, up to 78. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope Samaritan Bone Marrow Transplant Program — Phoenix, Arizona, United States
- City of Hope National Medical Center — Duarte, California, United States
- Rocky Mountain Cancer Center — Denver, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Shands Teaching Hospital, University of Florida — Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- Indiana Blood and Marrow Transplantation Center — Beech Grove, Indiana, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Kansas City Cancer Center — Kansas City, Missouri, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Nebraska Medical Center: Clarkson and University Hospitals — Omaha, Nebraska, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- University of Rochester Medical Center — Rochester, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Case Western Reserve University — Cleveland, Ohio, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.